Eupraxia Pharmaceuticals Inc. Common Stock Cash Flow Reinvestment Rate

Latest as of March 2020: 0.00x

Eupraxia Pharmaceuticals Inc. Common Stock cash flow reinvestment rate. Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $503.92K. Explore Eupraxia Pharmaceuticals Inc. Common Sto (EPRX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$503.92K
USD

Capital Expenditures

$0.00
USD

Eupraxia Pharmaceuticals Inc. Common Stock Cash Flow Reinvestment Rate by Year (None–None)

Eupraxia Pharmaceuticals Inc. Common Stock cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Eupraxia Pharmaceuticals Inc. Common Stock. For the full cash flow conversion analysis, see EPRX cash generation efficiency.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow